CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 141 enrolled
Drug / intervention
montelukast sodium +1 moredrug
Likely dose
montelukast sodium 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00863317
NCT00863317N/ACompleted
CompareCT.gov

A Randomized, Double Blind, Placebo Controlled Trial of Daily Montelukast for the Treatment of Viral Bronchiolitis

Medical College of Wisconsin·interventional·Posted Mar 18, 2009·Updated Jul 15, 2015

In Brief

A clinical study evaluating montelukast sodium and sucrose for Bronchiolitis. Completed, enrolled 141 participants across 1 site.

Detailed Summary

The primary rationale for this study is to evaluate the effect of once daily montelukast on duration of acute illness in infants with first-time bronchiolitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 18, 2009
Enrollment StartDec 1, 2008
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 17.3 years ago

Interventions

montelukast sodiumdrug

4mg granules daily for 14 days

sucroseother

table sugar as placebo daily for 14 days